Time for everyone who wants to see a LEGAL and PROSPEROUS cannabis market to make a phone call.

Washington State Medical marijuana Card  SSB 5052
Washington State Medical marijuana Card SSB 5052

This was just passed on to me. Please READ AND SHARE this so you know the level of proffessional a**hole* medical cannabis patients in Washington State are up against. These guys are slick and they have the ears of your legislators in Washington State…conact yours ASAP and tell them NO ON 5052!
-John
_________________
Specific to SSB 5052 right now….The following are members of the House of Representatives who are not with us and that need to hear from you:
View this email in your browser
Below is an email we received from a key contact in the Washington MJ Industry. We promised to send it along to help pass along information on key legislation.
—————————————————
The key bill we need (5052) is moving to the finish line. Time for everyone who wants to see a LEGAL and PROSPEROUS cannabis market to make a phone call. The list I have attached are House members who are trying to keep the ridiculous black market and bogus, unregulated “medicine” market alive. They need to hear from the legitimate business community……..
Feel free to pass this along. Need to make calls/send emails on Monday and Tuesday latest.
Specific to SSB 5052 right now….The following are members of the House of Representatives who are not with us and that need to hear from you:
Rep. Brian Blake (360) 786 – 7870
Rep. Cary Condotta (360) 786 – 7954
Rep. Liz Pike (360) 786 – 7812
Rep. Paul Harris (360) 786 – 7976
Rep. Sherry Appleton (360) 786 – 7934
Rep. Michelle Caldier (360) 786 – 7802
Rep. Matt Manweller (360) 786 – 7808
Rep. Ed Orcutt (360) 786 – 7990
Rep. Shelly Short (360) 786 – 7908
Rep. JT Wilcox (360) 786 – 7912
Rep. Lynda Wilson (360) 786 – 7994
Rep. Vincent Buys (360) 786 – 7854

The two highlighted in yellow are doing everything possible to kill the bill. Please remember that the United States Attorneys for Eastern and Western Washington have openly been directed by D.C. to KILL legal marijuana in our state if the medical mess (especially selling to minors via dispensary “medical cards”) is not regulated and cleaned up voluntarily by the state legislature– meaning simply creating a safe, legal, and regulated (testing, labels, etc.) medical community.
Please don’t forget to talk about JOBS! How many employees, what your starting wages are, what your plans for growing the business are.
Your direct ask is “ Will you vote yes on this critical piece of legislation?”

Here are some talking points created by the Washington Cannabusiness Association

Cannabis Patient Protection Act: Talking Points
In 2012, 55.7 percent of those who voted in our state’s General Election voted to approve Initiative 502 – 1,724,209 residents voted Yes. I-502 promised voters that Washington State would lead the nation in creating a legal marketplace for marijuana, keep pot out of the hands of minors and ensure that patients had access to the medicine they need. We are still working to fulfill that promise.

The Cannabis Patient Protection Act will finally honor the direction of the mandate that our constitutions approved in 2012. Some people ask, “don’t we already have a legal way of buying and selling marijuana, for patients and general consumers alike?” No, we don’t. What has been thriving, is a vast, persistent and totally unregulated marketplace for unlicensed operators to grow, and illegal retailers who purchase and sell untested and mislabeled marijuana products with zero protections to keep pot out of the hand of minors.

What we have at hand, what we can support and enforce, is a regulated, safe, tested and taxed system under which I-502 license holders operate.

We have heard a great deal of rumors concerning the evils of a registry to support tax breaks for legitimate patients. It’s not often that we see negative press in our state when it comes to making medicine cheaper, but I guess it is possible. The Cannabis Patient Protection Act will authorize the Department of Health to subcontract the creation of a registry to allow legitimate patients to take advantage of significant tax breaks to lower barriers to purchasing their doctor-prescribed medicine. Patients who choose not to join the registry may still grow up to four plants at a time for their own personal use. Of the 24 states that currently allow the sale of marijuana in some form, only Washington State currently lacks a registry for supporting the sale of marijuana to legitimate patients. In addition to following an opt-in structure for patients with authorization from a doctor, the registry will also dramatically reduce the likelihood that legal businesses will be defrauded by consumers without a doctor’s authorization seeking to illegitimately access the tax breaks for legitimate patients.

If we were talking about other types of consumer products or medicine prescribed by medical professionals, we would be outraged. We would have fixed this already. A June 30, 2014 story in the Seattle Times found that “testing shows that some marijuana strains are not what they purport to be in name, chemical content and genetics. This is particularly concerning for patients seeking pot low in intoxicants and high in pain-relief or other therapeutic qualities. One strain widely known for its high-CBD and popular among medical-marijuana patients is called Harlequin. But when Jessica Tonani [a Seattle biotech executive] and a leading Seattle pot-testing lab analyzed 22 samples of Harlequin from various growers and dispensaries, five of them were high in THC and had virtually no CBD, which means people trying to take medicine were just getting high instead.” That’s not just misleading legitimate patients and defrauding consumers, it can be dangerous. In the same story, the Times reports that “this problem can be significant for patients who don’t want to be stoned while working or behind the wheel. It’s even more so for pediatric patients. ‘You don’t want a 6-year-old with epilepsy being put on a bus under the influence of a psychedelic chemical,’” the biotech executive said. The Cannabis Patient Protection Act will ensure that the same strict regulations on testing and labeling are applied to the entire marketplace to protect consumer and patient safety.

The rampant unregulated marketplace we are working to address contains no protections to keep pot out of the hands of minors. In a December 6, 2014 editorial in the Seattle Times, editorial staff found that two out of the three unregulated retail stores in Seattle that they visited failed to ask for proof-of-age documentation during their purchase. A story broadcasted on KPLU on June 30, 2014 highlighted the ease with which minors can obtain a doctor’s authorization to purchase marijuana, exposing a major loophole in Washington’s current unregulated marijuana marketplace that leaves the door wide open to abuse. KPLU found that minors as young as 15 obtained green cards, some even getting authorized by doctors over Skype. The same story interviews two parents who discovered, after their 18-year-old son was expelled from school for selling pot on campus with his medical marijuana card, that “at 18, the senior student was able to see a doctor on his own.” His parents “had no right to view his medical records, even though they paid for his health care. And not only could he buy a lot of marijuana, he could grow it, too.” Imagine finding out your son was expelled for using his medical marijuana card that he was able to obtain without you even know it. The Cannabis Patient Protection Act will close these loopholes, protect kids and follow the direction of Washington voters in keeping marijuana out of the hands of minors while ensuring that legitimate patients can get the medicine they need.

The unregulated marketplace is literally exploding. A SeattlePI.Com story on December 29, 2014 reported on a derivative product of marijuana called hash oil, a product manufactured by using butane to extract the “honey” from cannabis to create a very concentrated version of marijuana. While licensed, regulated processors are subject to rigorous standards limiting them to certain methods, equipment, solvents, gases and mediums when creating marijuana extracts, the unregulated market is free from any oversight. The SeattlePI.Com story reports, “The process is so volatile that a spark from a refrigerator plugin can ignite the butane gas and blow a house off its foundation.”

The story continues to detail that this hasn’t stopped “medical” operators from building their own clandestine labs, which has led to tragedy in several cases throughout Washington from Puyallup to Mount Vernon.” Some cases that the story highlights include:

• Jan. 1, 2014: An explosion at a Kirkland apartment building blew out windows and expelled debris 25 feet from the building. The blast pushed walls out six to 10 inches and firefighters condemned parts of the building. One tenant told authorities she had previously reported drug activity at the site of the explosion.

• Jan. 7, 2014: One apartment exploded in the Mount Baker neighborhood of Seattle within 500 feet of Franklin High School. It was next to a flower shop.

• March 11, 2014: An explosion at a Lake City location shattered windows and moved a wall 3 inches.

• May 20, 2014: Several small explosions occurred at a Puyallup hash oil lab at a household whose residents included a 14-month-old. Reports from first responders read: “Butane canisters flung out from the explosion were still falling from the sky as far as 50 yards away from the building.” No one was injured, but a car was burned and a tricycle melted at the home. Federal charging documents say the two men allegedly involved, Kevin Weeks and Seth Cleek, continued to deliver marijuana-infused products to medical marijuana dispensaries for weeks after the explosions.

• Nov. 25, 2014: A fire caused at the site of an extensive hash oil lab destroyed a home in the Bitter Lake area of Seattle. Residents escaped the home uninjured, but the home was estimated a total loss.

We must fully implement I-502 if we are going to continue leading the nation on drug policy reform and marijuana legalization. The Cannabis Patient Protection Act lowers barriers to patient access, keeps pot out of the hands of minors, supports a safe product and ensures that only licensed practitioners following strict standards will be producing cannabis products. I urge you to join me in voting Yes.

MORE TO CONSIDER
The Cannabis Patient Protection Act: Myth vs. Reality
The Registry: dispelling fear, misconceptions and false rumors

MYTH: 2SSB 5052 requires medical marijuana patients to register and then be tracked by the government, threatening their privacy and putting them at risk for persecution.

REALITY: 2SSB 5052, The Cannabis Patient Protection Act, establishes a registry like the one used to track Sudafed, administered by the Department of Health and managed by a third party contractor (just like Sudafed).
· The reality is that only patients who wish to take advantage of the significant tax breaks must register. 2SSB 5052 doesn’t require anyone to register who doesn’t want to.

· The reality is patients who choose not to register may still grow up to four plants at a time for their personal use.

· The reality is of the 24 states that currently allow the sale of marijuana in some form; only Washington State currently lacks a registry for supporting the sale of marijuana to legitimate patients.

· The reality is enrolling on the registry benefits legitimate patients by authorizing significant tax breaks to lower any financial barrier to purchasing their doctor-prescribed medicine.

· The reality is the registry will dramatically reduce the likelihood that licensed, legal businesses will be defrauded by consumers without a doctor’s authorization seeking to illegitimately access the tax breaks for legitimate patients.
Selling & marketing marijuana to minors: getting honest about kids and pot

MYTH: The current unregulated marketplace is doing enough to reduce sales and marketing to minors.

REALITY: I-502 created strong protections in the legal marketplace requiring retailers to ask for photo IDs to ensure that no one under the age of 21 is purchasing marijuana. But 2SSB 5052 is the first real effort to address the pervasive unregulated marketplace which is not required to follow any such restrictions, undermining not only parental control but the will of voters when they overwhelmingly approved establishment of a well-regulated, adults-only system.

· The reality is that only licensed, appropriate medical personnel should be able to authorize the medical use of cannabis. 2SSB 5052 defines “medical” personnel who can prescribe cannabis.

· The reality is that a story broadcasted on KPLU on June 30, 2014, documented the ease with which minors can obtain authorization to purchase marijuana. KPLU found that minors as young as 15 obtained green cards, some even getting authorized by doctors over Skype. The Cannabis Patient Protection Act, 2SSB 5052, exposes and closes a major loophole in Washington’s current unregulated marijuana marketplace that leaves the door wide open to abuse.

· The reality is that in a December 6, 2014, editorial in the Seattle Times, editorial staff found that two out of the three unregulated retail stores in Seattle that they visited failed to ask for proof-of-age documentation during their purchase.
· The reality is 2SSB 5052 establishes a single, wholly-regulated system so that minors who cannot show proof of age with an ID, or a legitimate medical card will not be able to purchase marijuana.
Cannabis products for medical patients: the troubling truth about safety

MYTH: The current unregulated marketplace is providing safe and high-quality medicine to patients.

REALITY: None of the products sold to legitimate patients from the current unregulated marketplace is subject to any standards of testing or labeling. Despite assurances from unregulated growers, the lack of testing or accountability poses a real risk which is mitigated by 2SSB 5052.

· The reality is that a June 30, 2014, story in The Seattle Times found that, “testing shows that some marijuana strains are not what they purport to be in name, chemical content and genetics. This is particularly concerning for patients seeking pot low in intoxicants and high in pain-relief or other therapeutic qualities. One strain widely known for its high-CBD and popular among medical-marijuana patients is called Harlequin. But when…a leading Seattle pot-testing lab analyzed 22 samples of Harlequin…five of them were high in THC and had virtually no CBD, which means people trying to take medicine were just getting high instead.”

· The reality is Dr. Michelle Sexton, a naturopath, founder of PhytaLAB and an adviser to the state Liquor Control Board, was quoted in the same Seattle Times story that, “misnaming and inconsistent chemical profiles are extremely common.”

REALITY: All marijuana grown, processed and sold by I-502 license holders is subject to rigorous testing by credentialed state-licensed labs. 2SSB 5052 ensures the measures that keep 502-customers safe apply to all retailers and all consumers – especially medical consumers.

The information above is not a solicitation on the part of FGI. We are merely passing along information we thought might be of interest or benefit.
Copyright © 2015 Forever Green Indoors, All rights reserved.